CN1679572A - Medicinal injection for treating primary mimic tic - Google Patents

Medicinal injection for treating primary mimic tic Download PDF

Info

Publication number
CN1679572A
CN1679572A CN 200510002685 CN200510002685A CN1679572A CN 1679572 A CN1679572 A CN 1679572A CN 200510002685 CN200510002685 CN 200510002685 CN 200510002685 A CN200510002685 A CN 200510002685A CN 1679572 A CN1679572 A CN 1679572A
Authority
CN
China
Prior art keywords
tic
mimic
anisodamine
treatment
lignocaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510002685
Other languages
Chinese (zh)
Inventor
唐传志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200510002685 priority Critical patent/CN1679572A/en
Publication of CN1679572A publication Critical patent/CN1679572A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An injection for treating primary facial spasm is proportionally prepared from lidocaine, anisodamine and diazepam. Its advantages are high curative effect and low by-effect.

Description

A kind of medicaments injection for the treatment of primary mimic tic
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of medicaments injection for the treatment of primary mimic tic.
Background technology
Primary mimic tic is department of neurology commonly encountered diseases, frequently-occurring disease, shows that mainly the histrionic muscles that nervus facialis is arranged be can't help, irregular, painless paroxysmal is twitched, and the cause of disease is not fully aware of at present.At present, this disease is not had well-content Therapeutic Method both at home and abroad, adopt medication effect poor, the time is slow; And adopt the modus operandi risk bigger.As, CN1052158's the prosopalgic scheme of Drug therapy of " a kind of pure Chinese medicine trident loose and preparing process " was disclosed on the Chinese patent communique May 10 in 2000, it has adopted 10 Chinese herbal medicine to be made into the traditional Chinese medicine mouth treatment nervi trigeminus of taking medicine by a certain percentage, not only dose is big, the time cycle is long, and the cost height.For this reason, " treating the preparation method of prosopalgic compositions and fumigant " of a kind of CN1490024 disclosed on April 21st, 2004, the fumigant of being made by Flos Carthami, Herba Schizonepetae, Radix Saposhnikoviae and Herba speranskiae tuberculatae directly acts on face area, and this method is safer, but is difficult in radical cure in a short time.
Summary of the invention
In order to address the above problem, the purpose of this invention is to provide a kind of instant effect, treatment cycle weak point, cure rate than higher a kind of medicaments injection for the treatment of primary mimic tic.
The object of the present invention is achieved like this: a kind of medicaments injection for the treatment of primary mimic tic, constitute by lignocaine, Anisodamine and stable component, with the Anisodamine volume parts is benchmark, wherein the capacity of each composition is: 1% lignocaine: 10% Anisodamine: 10% is stable, according to 5~10: 1~2: 8 preparations.
Compound method of the present invention is with after being purchased lignocaine and being 1% with the pump pickle diluted concentration, prepares according to above-mentioned capacity with 10% Anisodamine again, is expelled on patient's the focus with 10% diazepam solution respectively to get final product.In above-mentioned composition, the content of lignocaine is preferably 5ml, 10% stable 8ml, 10% Anisodamine 1ml.
Because the present invention has adopted said composition to inject, not only can remove vasospasm, alleviate compressing stimulation, the elimination risk factor of abnormal vascular to nervus facialis, and the effect of lignocaine and stabile nerve anesthesia, behind the nervus facialis dry injection, can make excitement, the conductivity of nervus facialis be suppressed and block, thereby eliminate the control of facial spasm outbreak.In addition, stabile of flaccid muscles, calm, angst resistance effect also helps the control of facial spasm outbreak.Compound method of the present invention is simple, and is evident in efficacy, and the effect of paying is little, and treatment is a kind of ideal injection liquid for the treatment of the intractable primary mimic tic extensively.
The specific embodiment
Below in conjunction with embodiment the present invention is further specified.
Embodiment 1
Is to get 5ml after 1% with the lignocaine that is purchased with the pump pickle diluted concentration, prepares with 10% Anisodamine 1ml, standby; With the sharp leading edge of the sick side breast of patient is point of puncture, and behind the routine disinfection skin, it is subcutaneous to use medical No. seven injection needles to thrust, and proceeds inserting needle to mastoid process root leading edge then, and the fold mid point is an entry point before the also optional ear-lobe, seeks nervus facialis at 2.5~3cm place and does.When nervus facialis is done in the thorn, slight distending pain sense is arranged and can bring out or increase the weight of facial spasm, after confirming accurately, mixed liquor slowly be expelled to patient's focus on according to 5: 1 volume parts 1% standby lignocaine 5ml and 10% Anisodamine 1ml, observed 6 minutes, after the facial paralysis symptom occurring, inject 10% stable 8ml.Also can inject ethanol or vitamin B1 or B12 in right amount.Pulling out sterilizes behind the pin gets final product.Treatment time is a shot every other day, till facial spasm stops fully, and general treatment 2~5 times.
Embodiment 2
Is to get 10ml after 1% with the lignocaine that is purchased with the pump pickle diluted concentration, prepares with 10% Anisodamine 2ml, standby.Acies before the sick side breast of patient point is sought nervus facialis and is done, and when nervus facialis in the acupuncture is done, slight distending pain sense is arranged, and can bring out or increase the weight of facial spasm; After the affirmation, 1% standby lignocaine 10ml and 10% Anisodamine 2ml mixed liquor slowly are expelled on the focus, observed 5 minutes, the facial paralysis symptom appears and after, inject 10% stable 8ml.Inject once every other day, till facial spasm stops fully.
Through the treatment, the tic complete obiteration and in half a year not the recidivist for the recovery from illness; The canthus or the corners of the mouth have slight tic and persistent period relatively to lack, and are produce effects; Duration of seizure and persistent period obviously reduce, for taking a turn for the better; No obvious alleviator before and after the treatment is for invalid.Since 1986, treat facial spasm disease 7600 many cases with this ruling by law, controlled primary mimic tic patient 731 examples in 1994 and twice extraction successively in 2002, male 350 examples, women 381 examples, the men and women compares=1: 1.10, and the age accounted for 79.9% in 40 years old at 24~75 years old; Obtaining total effective rate is 99.3%, and cure rate keeps more than 93.4%, 3 year not that relapse rate is 73.7%.
See Table 1,731 routine patients are carried out two groups of therapeutic outcome statistical dispositions: one group of treatment group that the medicaments injection that is employing the present invention prepares is treated the patient; Another group adopts the matched group with the common drug treatment, and two groups differ highly significant, and the effect of treatment group is better than matched group.
See Table 2, the patient in 3 years carries out observation of curative effect to 328 routine facial spasm, handles by statistics, and two groups have evident difference, and treatment group long-term effect is better than matched group.

Claims (2)

1, a kind of medicaments injection for the treatment of primary mimic tic, it is characterized in that: this medicaments injection stable is mixed respectively by 1% lignocaine and 10% Anisodamine and 10%, and wherein the Capacity Ratio of each composition is: 1% lignocaine: 10% Anisodamine: 10% stabile mixed liquor is 5~10: 1~2: 8.
2, a kind of medicaments injection for the treatment of primary mimic tic according to claim 1, it is characterized in that: described medicaments injection stable is mixed respectively by 1% lignocaine and 10% Anisodamine and 10%, and wherein the Capacity Ratio of each composition is: 1% lignocaine: 10% Anisodamine: 10% stabile mixed liquor is 5: 1: 8.
CN 200510002685 2005-01-26 2005-01-26 Medicinal injection for treating primary mimic tic Pending CN1679572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510002685 CN1679572A (en) 2005-01-26 2005-01-26 Medicinal injection for treating primary mimic tic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510002685 CN1679572A (en) 2005-01-26 2005-01-26 Medicinal injection for treating primary mimic tic

Publications (1)

Publication Number Publication Date
CN1679572A true CN1679572A (en) 2005-10-12

Family

ID=35066587

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510002685 Pending CN1679572A (en) 2005-01-26 2005-01-26 Medicinal injection for treating primary mimic tic

Country Status (1)

Country Link
CN (1) CN1679572A (en)

Similar Documents

Publication Publication Date Title
CN102648950A (en) Traditional Chinese medicinal composition for eliminating body fatigue and movement disorder and relieving pains
CN103977194A (en) Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot
US20240189382A1 (en) Formula for inhibiting aging regeneration repair
CN1251736C (en) Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
CN100512846C (en) A medicinal tincture and method for preparing the same
CN104958429A (en) Traditional Chinese medicinal composition for treating geriatric fracture and preparation method thereof
CN104435374B (en) A kind of acupoint injection therapy liquid for the treatment of subjective tinnitus and preparation method thereof
CN1056762C (en) Brain-refreshing analgesic powder medicine
CN1679572A (en) Medicinal injection for treating primary mimic tic
CN1679588A (en) Medicinal composition for treating mimic tic
CN111773262A (en) Acupuncture point combination method for treating cold and acupuncture point patch used cooperatively
CN102526252B (en) Mongolian medicine pillow for treating cervical spondylosis
CN105343269A (en) Chinese herb extract with anesthetic effect and preparation method thereof
CN112237604A (en) Traditional Chinese medicine incense for reducing epidemic infection and preparation process thereof
CN112121079A (en) Acupuncture needle capable of enhancing pain relieving efficacy and preparation method and application thereof
Changqing et al. Forty-two cases of greater occipital neuralgia treated by acupuncture plus acupoint-injection
CN107029112A (en) A kind of denseflower bulbophyllum herb clearing lung-heat agent
CN108272991A (en) A kind of anaesthetic and its manufacturing process of removing heat from blood blood pressure lowering
CN108686178B (en) Traditional Chinese medicine acupoint emplastrum for treating Parkinson's disease and preparation method thereof
CN1286512C (en) Impediment pain tonic wine
CN1264544C (en) Nasal suppository for treating thinitis
CN104147216B (en) A kind of Chinese medicine composition treating thoracic tuberculosis
CN105167477A (en) Complex medicine core formula for refreshing and resisting fatigue
CN112022990A (en) Traditional Chinese medicine incense for relieving migraine and preparation process thereof
CN102988403A (en) Injection medicine composition used for treating facial paralysis in acute stage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication